Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cortexyme Inc (CRTX)

Cortexyme Inc (CRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cortexyme Inc 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 USA

P: 415-910-5717

Description:

Cortexyme Inc. is a clinical-stage biopharmaceutical company. It is focused on providing disease-modifying therapeutics to treat Alzheimer's and other degenerative diseases. The company's drug candidate consists of COR388 which is in clinical stage. Cortexyme Inc. is based in San Francisco, United States.

Key Statistics

Overview:

Market Capitalization, $K 2,606,134
Shares Outstanding, K 29,686
Annual Sales, $ 0 K
Annual Net Income, $ -76,850 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -21,750 K
60-Month Beta 0.84
% of Insider Shareholders 20.20%
% of Institutional Shareholders 61.84%
Float, K 23,689
% Float 79.80%

Growth:

1-Year Return 57.90%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/16/21
Earnings Per Share ttm -2.94
EPS Growth vs. Prev Qtr 5.13%
EPS Growth vs. Prev Year -23.33%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CRTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -52.77%
Return-on-Assets % -47.62%
Profit Margin % 0.00
Net Margin % 2.95
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 19.35
Book Value/Share 4.80
Interest Coverage 0.00
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar